Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort [NA]
A prospective interventional multicentre national cohort investigating hepatocellular carcinoma treated with targeted radionuclide therapy (…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Liver and Spleen Stiffness to Predict the Presence of Esaphageal Varices in Cirrhotic With Advanced HCC
This clinical trial investigates whether measurements of liver and spleen stiffness can predict the presence of esophageal varices in patien…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC) [NA]
This clinical trial update notes that Terumo Europe N.V. is recruiting for a study of BioPearl microspheres loaded with doxorubicin to treat…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients with Cirrhosis
Clinical trial evaluating the MSEPT9 biomarker for predicting hepatocellular carcinoma occurrence in patients with cirrhosis; the study is n…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Neoadjuvant Nivolumab with CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 neoadjuvant trial evaluating nivolumab with a CCR2/5 inhibitor or anti-IL-8 in non-small cell lung cancer and hepatocellular carcino…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma
A clinical trial investigates whether immunophenotyping peripheral blood mononuclear cells can early predict response to immunotherapy in he…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: A Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular Carcinoma [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of biodegradable magnesium embolic microspheres for non-resectable hepatocellular …
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?
An ongoing clinical study is evaluating whether hepatic-splenic elastography can predict recurrence risk after radiofrequency ablation for h…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
An observational study evaluating intra-arterial therapies for primary liver diseases, including hepatocellular carcinoma and cholangiocarci…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Use of Machine-learning Algorithms, Biomarkers and Measures of Quality of Life to Personalize Medical Management of Liver and Heart Transplant Recipients
Clinical trial update on using machine-learning, biomarkers, and quality-of-life measures to personalize care for liver and heart transplant…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT [NA]
Clinical trial update describing a study of combining transjugular intrahepatic portosystemic shunt (TIPS) with lenvatinib and a PD-1 inhibi…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation
A clinical trial update describing a study that compares the incidence of delirium in liver transplant patients when different anesthetic ag…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers [Phase 2]
This Phase 2 trial aims to evaluate whether reducing the dosing frequency of immune checkpoint inhibitors is feasible across advanced cancer…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer [Phase 2]
This Phase 2 trial update indicates recruitment is ongoing to compare stereotactic radiosurgery versus radiofrequency ablation for hepatocel…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC [Phase 2]
This update describes a Phase 2 clinical trial evaluating tislelizumab alone or with lenvatinib as neoadjuvant treatment for resectable recu…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery [Phase 2]
Phase 2 clinical trial evaluating lenvatinib as adjuvant therapy to prevent recurrence after curative surgery in high-risk hepatocellular ca…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma [Phase 3]
The ABC-HCC trial is a Phase 3 study evaluating atezolizumab plus bevacizumab versus transarterial chemoembolization in intermediate-stage h…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial investigating radiation-assisted major hepatectomy to selectively treat large unifocal hepatocellular carcinoma is …
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating Fruquintinib as second-line therapy after immune checkpoint inhibitors in unresectable hepatocellular carc…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma [Phase 3]
This is a Phase 3 clinical trial evaluating perioperative hepatocellular carcinoma treatment with a combination of camrelizumab, apatinib, a…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
This clinical trial is investigating circulating tumor mitochondrial DNA as a biomarker to monitor recurrence in patients with hepatocellula…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: A Comparative Analysis of Ultrasound's Accuracy in Diagnosing HC Using Histopathology as Gold Standard
This clinical trial update reports on a study comparing ultrasound accuracy for diagnosing hepatocellular carcinoma using histopathology as …
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma
This clinical trial update describes evaluating the biomarker AKR1B10 for monitoring postoperative recurrence of hepatocellular carcinoma; t…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular Carcinoma [NA]
A clinical trial evaluating prehabilitation during conversion therapy for unresectable hepatocellular carcinoma and its effects on postopera…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Mts105 for Advanced Hepatocellular Carcinoma [Phase 1]
A Phase 1 clinical trial update indicates Mts105 for advanced hepatocellular carcinoma is currently recruiting.